Bibek Raj Bhattarai

Mr. Bibek Raj Bhattarai

Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
BABikash Adhikari
Bikash Adhikari
BMBishnu P Marasini
Bishnu P Marasini
Binod RayamajheeBinod Rayamajhee
Binod Rayamajhee
Bibek Raj BhattaraiBibek Raj Bhattarai
Bibek Raj Bhattarai
GLGanesh Lamichhane
Ganesh Lamichhane
NPNiranjan Parajuli
Niranjan Parajuli

23 November 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
Anup AdhikariAnup Adhikari
Anup Adhikari
Bibek Raj BhattaraiBibek Raj Bhattarai
Bibek Raj Bhattarai
AAAshika Aryal
Ashika Aryal
NTNiru Thapa
Niru Thapa
PKPuja Kc
Puja Kc
NPNiranjan Parajuli
Niranjan Parajuli
Unnatural amino acids have gained significant attention in protein engineering and drug discovery as they allow the evolution of proteins with enhanced stability and activity. The incorporation of unnatural amino acids into proteins offers a rational approach to engineer enzymes for designing efficient biocatalysts that exhibit versatile physicochemical properties and biological functions. This review highlights the biological and synthetic routes of unnatural amino acids to yield a modified protein with altered functionality and their incorporation methods. Unnatural amino acids offer a wide array of applications such as antibody-drug conjugates, probes for change in protein conformation and structure–activity relationships, peptide-based imaging, antimicrobial activities, etc. Besides their emerging applications in fundamental and applied science, systemic research is necessary to explore unnatural amino acids with novel side chains that can address the limitations of natural amino acids.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Babita AryalBabita Aryal
Babita Aryal
BABikash Adhikari
Bikash Adhikari
NANiraj Aryal
Niraj Aryal
Bibek Raj BhattaraiBibek Raj Bhattarai
Bibek Raj Bhattarai
KKKaran Khadayat
Karan Khadayat
NPNiranjan Parajuli
Niranjan Parajuli
Acacia catechu (L.f.) Willd is a profoundly used traditional medicinal plant in Asia. Previous studies conducted in this plant are more confined to extract level. Even though bioassay‐based studies indicated the true therapeutic potential of this plant, compound annotation was not performed extensively. This research is aimed at assessing the bioactivity of different solvent extracts of the plant followed by annotation of its phytoconstituents. Liquid chromatography equipped with high resolution mass spectrometry (LC‐HRMS) is deployed for the identification of secondary metabolites in various crude extracts. On activity level, its ethanolic extract showed the highest inhibition towards α-amylase and α‐glucosidase with an IC50 of 67.8 ± 1 μg/mL and 10.3 ± 0.1 μg/mL respectively, inspected through the substrate‐based method. On the other hand, the plant extract showed an antioxidant activity of 23.76 ± 1.57 μg/mL, measured through radical scavenging activity. Similarly, ethyl acetate and aqueous extracts of A. catechu showed significant inhibition against Staphylococcus aureus with a zone of inhibition (ZoI) of 13 and 14 mm, respectively. With the LC‐HRMS‐based dereplication strategy, we have identified 28 secondary metabolites belonging to flavonoid and phenolic categories. Identification of these metabolites from A. catechu and its biological implication also support the community‐based usage of this plant and its medicinal value.

27 August 2020 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
KKKaran Khadayat
Karan Khadayat
DSDawa Dindu Sherpa
Dawa Dindu Sherpa
KMKrishna Prakash Malla
Krishna Prakash Malla
SSSunil Shrestha
Sunil Shrestha
NRNabin Rana
Nabin Rana
NPNiranjan Parajuli
Niranjan Parajuli
Streptomyces are widely used for the production of secondary metabolites with diverse biological activities, including antibiotics. The necessity of alternative antimicrobial agents against multidrug-resistant pathogens is indispensable. However, the production of new therapeutics is delayed in recent days. Thus, the isolation of new Streptomyces species has drawn attention. Nepal—a country rich in biodiversity—has got high possibilities for the discovery of members of actinomycetes, especially in the higher altitudes. However, in vain, only a few screening research works have been reported from Nepal to date. Streptomyces species were isolated on ISP4 media, and characterization was performed according to morphological similarity and 16S rRNA sequence similarity using bioinformatic tools. Ethyl acetate extracts of Streptomyces species were prepared, and the antimicrobial activity was carried out using agar well diffusion technique. In this report, 18 Streptomyces species isolated from the soil were reported based on sequence analysis of 16S rRNA. Among them, 12 isolates have shown antibacterial activity against extended-spectrum beta-lactamase- (ESBL-) producing Escherichia coli. Here, we have also analyzed 16S rRNA in 27 Streptomyces species whose whole-genome sequence is available, which has revealed that some species have multiple copies of the 16S gene (∼1.5 kb) with significant variation in nucleotides. In contrast, some Streptomyces species shared identical DNA sequences in multiple copies of 16S rRNA. The sequencing of numerous copies of 16S rRNA is not necessary, and the molecular sequencing of this region is not sufficient for the identification of bacterial species. The Streptomyces species-derived ethyl acetate extracts from Nepalese soil demonstrate potential activity against ESBL-producing E. coli. Thus, they are potential candidates for antibiotics manufacturing in the future.

7 December 2021 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
BABikash Adhikari
Bikash Adhikari
Babita AryalBabita Aryal
Babita Aryal
Bibek Raj BhattaraiBibek Raj Bhattarai
Bibek Raj Bhattarai
With the emergence of epidemics, pandemics, and infectious diseases, several research activities have been carried out on natural products to tackle them. As there are structural diversities in natural products, researchers are focused on exploring them for treatment and/or management of various infections and/or diseases. Acacia catechu (L.f.) Willd. belonging to the order Fabales and family Fabaceae shows a wide range of pharmacological functions in the management of diseases in humankind. This review was carried out to gather and provide information about the chemical constituents and pharmacological activities of A. catechu through the literature survey of scientific articles. On preliminary assessments, A. catechu is demonstrated as a significant wellspring of bioactive compounds with a wide range of biological and pharmaceutical applications such as antidiabetic, antioxidant, antimicrobial, anticancer, antidiarrheal, anti-inflammatory, antiviral, hepatoprotective, immunomodulatory, and so on. Although the metabolites from the plant are reported with diverse pharmacological applications, there is little information in regards to toxicity and clinical trials on bioactive compounds of this plant. Further research on diverse bioactive compounds from the plant is required to develop them as a successful potent drug.

6 May 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Babita AryalBabita Aryal
Babita Aryal
PNPurushottam Niraula
Purushottam Niraula
KKKaran Khadayat
Karan Khadayat
BABikash Adhikari
Bikash Adhikari
DCDadhiram Khatri Chhetri
Dadhiram Khatri Chhetri
NPNiranjan Parajuli
Niranjan Parajuli
Natural products have been the center of attraction ever since they were discovered. Among them, plant-based natural products were popular as analgesics, anti-inflammatory, antidiabetic, and cosmetics and possess widespread biotechnological applications. The use of plant products as cosmetics and therapeutics is deep-rooted in Nepalese society. Although there are few ethnobotanical studies conducted, extensive research of these valuable medicinal plants has not been a priority due to the limitation of technology and infrastructure. Here, we selected 4 traditionally used medicinal plants to examine their bioactive properties and their enzyme inhibition potential. α-Glucosidase and α-amylase inhibitory activities were investigated using an in vitro model followed up by antioxidant and antimicrobial activities. The present study shows that ethyl acetate fraction of Melastoma melabathrium (IC50 9.10.3µg/mL) and water fraction Acacia catechu (IC50 9.00.6µg/mL) exhibit strong α-glucosidase inhibition. Likewise, the highest α-amylase inhibition was shown by crude extracts of Ficus religiosa (IC50 29.21.2µg/mL) and ethyl acetate fractions of Shorea robusta (IC50 69.31.1µg/mL), and the highest radical scavenging activity was shown by F. religiosa with an IC50 67.40.6µg/mL. Furthermore, to identify the metabolites within the fractions, we employed high-resolution mass spectrometry (LC-HRMS) and annotated 17 known metabolites which justify our assumption on activity. Of 4 medicinal plants examined, ethyl acetate fraction of S. robusta, ethyl acetate fraction of M. melabathrium, and water or ethyl acetate fraction of A. catechu extracts illustrated the best activities. With our study, we set up a foundation that provides authentic evidence to the community for use of these traditional plants. The annotated metabolites in this study support earlier experimental evidence towards the inhibition of enzymes. Further study is necessary to explore the clinical efficacy of these secondary molecules, which might be alternatives for the treatment of diabetes and pathogens.